Contact us

Prolacta Formula Fortifier Starts Trial For Newborns With Rare Heart Condition

Read Here

Prolacta Formula Fortifier Starts Trial For Newborns With Rare Heart Condition

This article was originally published in The Rose Sheet 28 Feb 2017

Executive Summary

Prolacta Bioscience developed human milk-based formula fortifier for full-term infants born with conditions that make them vulnerable to nutrition deficiencies. Pending results from research at 12 US hospitals, the product would roll out commercially in 2018.